세계의 독성 시험 시장 예측(-2030년) : 제품별, 시험 유형별, 방법별, 기술별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Toxicology Testing Market is growing at a CAGR of 15.9% during the forecast period. Toxicology testing involves evaluating the effects of substances on living organisms to assess potential hazards to human health and the environment. It determines the safety, toxicity, and risks associated with chemicals, pharmaceuticals, consumer products, and environmental pollutants. Its importance lies in safeguarding public health by identifying and mitigating risks, aiding regulatory compliance, and guiding product development.

According to NCBI, for every 10,000 compounds synthesized in the discovery phase, only 250 reach the preclinical phase, ultimately resulting in one approved drug by the FDA.

Market Dynamics:

Driver:

Increasing R&D activities

Industries such as pharmaceuticals, biotechnology, and chemical manufacturing are continually exploring novel compounds, formulations, and products. Toxicology testing plays a pivotal role in these sectors by evaluating the safety, efficacy, and potential risks of these innovations before market introduction. Moreover, robust toxicological assessments ensure compliance with regulatory standards and help mitigate adverse effects on human health and the environment. The need for thorough toxicological testing is growing as R&D efforts to address changing consumer demands and technological breakthroughs rise, making it an essential step in the creation and approval of novel medications, chemicals, and products.

Restraint:

Complexity in data interpretation

The complex and varied data produced by many experiments and cutting-edge technologies presents analytical difficulties that make it difficult to analyze and translate into useful insights. Accurate assessment of this complexity necessitates specific knowledge, advanced instruments, and standardized frameworks. Errors or uncertainty when interpreting these complex statistics can impair decision-making in risk assessments, regulatory filings, and product development, thereby impeding market approvals and developments.

Opportunity:

Growing demand for alternative testing methods

Advanced technologies such as in vitro assays, organoids, microfluidics systems, and computational models offer promising alternatives for toxicology assessments, providing more accurate, cost-effective, and ethical testing avenues. Companies investing in research and development to validate and commercialize these alternative methods stand to capitalize on this growing demand. Moreover, the widespread adoption of these alternatives also streamlines testing processes, fosters quicker results, and aligns with the global trend towards more humane and predictive toxicology evaluations. Thus, there is propelling market expansion.

Threat:

Regulatory changes

Evolving and stringent regulations governing safety assessments necessitate continuous adaptation and compliance, impacting testing methodologies, validation requirements, and timelines for product approvals. Sudden shifts in regulatory standards or the introduction of new guidelines may lead to uncertainties, increased costs, and delays in the approval process. Failure to promptly align with new standards could result in non-compliance penalties, reduced competitiveness, and impediments to market access, posing challenges for companies in maintaining efficiency and meeting evolving requirements within the toxicology testing market.

COVID-19 Impact

The COVID-19 outbreak initially affected operations and research due to lockdowns and redirected resources towards pandemic-related studies. Delays in trials and regulatory processes ensued, slowing down product approvals. However, the crisis highlighted the criticality of toxicology testing in vaccine development and drug safety assessments, elevating its importance. The industry adapted with remote work and virtual trials, fostering innovation and digitalization. Increased awareness of safety evaluations resulted in a renewed emphasis on robust testing methodologies, paving the way for a resilient recovery post-pandemic.

The genetic toxicology testing segment is expected to be the largest during the forecast period

The genetic toxicology testing segment is estimated to hold the largest share. Genetic toxicology testing employs assays to evaluate a substance's ability to induce mutations, chromosomal aberrations, or DNA damage, which is crucial in identifying potential carcinogens or harmful compounds. These tests encompass in vitro and in vivo methods, such as the Ames test, micronucleus assay, and comet assay, to comprehensively analyze genotoxicity. Moreover, understanding genetic toxicity aids in determining the safety of pharmaceuticals, chemicals, pesticides, and consumer products, contributing significantly to regulatory evaluations, and ensuring the protection of human health and the environment from harmful genetic alterations.

The in-vivo testing segment is expected to have the highest CAGR during the forecast period

The in-vivo testing segment is anticipated to have lucrative growth during the forecast period. In vivo tests refer to a type of experiment that is carried out within a whole, living organism, such as a plant or animal. It helps to determine toxicity levels, adverse reactions, and potential health hazards, providing crucial data for regulatory assessments and safety evaluations. Moreover, these tests, despite ethical considerations, remain essential for comprehensively understanding the biological effects of substances and ensuring the protection of human health and the environment from potentially harmful compounds.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing industrialization, stringent regulatory guidelines, and rising awareness regarding environmental safety. Advancements in technology and expanding pharmaceutical and biotechnology sectors, coupled with the demand for toxicological evaluations in the cosmetics and food industries, drive market expansion. Moreover, countries like China, India, Japan, and South Korea are pivotal contributors due to their expanding economies and growing research initiatives. This market's growth is fuelled by the emphasis on product safety assessment and the need for reliable toxicology testing methods.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks, heightened focus on product safety, and technological advancements. The region's well-established pharmaceutical and biotechnology industries, along with increased R&D activities, propel market expansion. Moreover, rising concerns about chemical exposure, coupled with the need for efficient toxicological evaluations in various sectors, including healthcare, cosmetics, and environmental monitoring, are driving market growth. Key contributors like the United States and Canada witness continual advancements in testing methodologies, fostering innovation and market penetration.

Key players in the market:

Some of the key players in the Toxicology Testing Market include Abbott Laboratories, Eurofins Scientific, Laboratory Corporation Of America Holdings, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technolgies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., Bioivt and Gentronix.

Key Developments:

In November 2023, Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In September 2023, Thermo Fisher Scientific and National Minority Quality Forum Collaborate to support biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or health condition being studied, including U.S. Food and Drug Administration requirements around diversity action plans.

Products Covered:

• Instruments
• Reagents and Kits
• Other Products

Test Types Covered:

• Genetic Toxicology Testing
• Carcinogenicity Testing
• Developmental and Reproductive Toxicology Testing
• Other Test Types

Methods Covered:

• Biochemical Testing
• Hematology Testing
• Pathology Testing

Technologies Covered:

• In-vivo Testing
• In-vitro Testing

End Users Covered:

• Food and Beverage Industry
• Pharmaceutical and Biotechnology Companies
• Cosmetics and Personal Care Industry
• Academic and Research Institutions
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Toxicology Testing Market, By Product

• 5.1 Introduction
• 5.2 Instruments
• 5.3 Reagents and Kits
• 5.4 Other Products

6 Global Toxicology Testing Market, By Test Type

• 6.1 Introduction
• 6.2 Genetic Toxicology Testing
• 6.3 Carcinogenicity Testing
• 6.4 Developmental and Reproductive Toxicology Testing
• 6.5 Other Test Types

7 Global Toxicology Testing Market, By Method

• 7.1 Introduction
• 7.2 Biochemical Testing
• 7.3 Hematology Testing
• 7.4 Pathology Testing

8 Global Toxicology Testing Market, By Technology

• 8.1 Introduction
• 8.2 In-vivo Testing
• 8.3 In-vitro Testing

9 Global Toxicology Testing Market, By End User

• 9.1 Introduction
• 9.2 Food and Beverage Industry
• 9.3 Pharmaceutical and Biotechnology Companies
• 9.4 Cosmetics and Personal Care Industry
• 9.5 Academic and Research Institutions
• 9.6 Other End Users

10 Global Toxicology Testing Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Abbott Laboratories
• 12.2 Eurofins Scientific
• 12.3 Laboratory Corporation Of America Holdings
• 12.4 Thermo Fisher Scientific, Inc.
• 12.5 Danaher Corporation
• 12.6 Agilent Technolgies, Inc.
• 12.7 Catalent, Inc.
• 12.8 Bio-Rad Laboratories, Inc.
• 12.9 Bioivt
• 12.10 Gentronix